MARY HITCHCOCK MEMORIAL HOSP
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $22M
- Transactions
- 3,682
- Companies
- 40
- Average per transaction
- $5,971
Who reported the payments
| Masimo Corporation | $4,015,054 |
| Merck | $2,643,759 |
| AbbVie | $1,543,832 |
| Vertex | $1,173,823 |
| Eli Lilly | $997,602 |
| Tesaro, Inc. | $915,267 |
| Takeda Pharmaceuticals U.S.A., Inc. | $669,592 |
| Genentech, Inc. | $644,986 |
| W. L. Gore & Associates, Inc. | $550,273 |
| Bristol Myers Squibb | $514,661 |
| Novartis | $495,863 |
| ZOLL Medical Corporation | $456,631 |
| Pfizer | $423,945 |
| Medtronic | $379,205 |
| Amgen | $371,205 |
| Daiichi Sankyo Inc. | $334,056 |
| Boston Scientific | $331,438 |
| Edwards Lifesciences | $320,271 |
| GSK | $319,731 |
| Medical Device Business Services, Inc. | $264,568 |
| Gilead | $264,046 |
| Vascular Graft Solutions Inc | $242,379 |
| Abbott | $216,920 |
| Grifols Therapeutics LLC | $189,189 |
| Astrazeneca UK Limited | $176,515 |
| Eisai Inc. | $168,992 |
| Sanofi Pasteur Inc. | $166,355 |
| GW Research Limited | $157,717 |
| E.r. Squibb & Sons, L.L.C. | $153,601 |
| Fresenius Kabi USA, LLC | $141,580 |
| Boehringer Ingelheim | $139,472 |
| Medacta USA, Inc. | $134,187 |
| Incyte Corporation | $129,649 |
| Octapharma USA, Inc. | $126,628 |
| Inari Medical, Inc. | $125,319 |
| AstraZeneca | $119,449 |
| Sun Pharmaceutical Industries Inc. | $111,144 |
| Neuropace, Inc. | $109,899 |
| KARL Storz Endoscopy-america | $92,953 |
| Angiodynamics, Inc. | $91,000 |